SCHEMBL6159963

SCHEMBL6159963

Cc1ccc(S(=O)(=O)N(c2ccccc2)c2ccc(CN3CC(S)CC3=O)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.46
ALDH1A1 P00352 4/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
MAPT P10636 1/20 0.42
CNR2 P34972 5/20 0.41
CNR1 P21554 2/20 0.41
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6158076 0.88 SMN1; SMN2 (0.49) SMN1; SMN2ALDH1A1KMT2AMEN1MAPT
SCHEMBL6159283 0.84 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1KMT2AMEN1MAPT
SCHEMBL6159057 0.82 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1KMT2AMEN1MAPT
SCHEMBL6160276 0.78 HPGD (0.52) SMN1; SMN2ALDH1A1KMT2AMEN1HPGD
SCHEMBL6158969 0.74 ALDH1A1 (0.58) ALDH1A1KMT2AMAPTCNR2CNR1
SCHEMBL6158771 0.74 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1HPGDTSHRMAPT
SCHEMBL6158482 0.73 HPGD (0.61) SMN1; SMN2ALDH1A1HPGDTSHRMAPT
SCHEMBL6159392 0.73 HPGD (0.61) SMN1; SMN2ALDH1A1HPGDTSHRMAPT
SCHEMBL3697451 0.72 PKM (0.71) ALDH1A1KMT2AMAPTCNR2CNR1
SCHEMBL6158520 0.72 ALDH1A1 (0.61) ALDH1A1KMT2ACNR2CNR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 SMN1; SMN2 3819/4885ALDH1A1 905/4885KMT2A 1898/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 SMN1; SMN2 3509/4885ALDH1A1 877/4885KMT2A 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.